Stryker Posts Solid Results as Recon Market Strengthens
SYK beat consensus revenue and EPS as it benefited from an improving orthopedic implant market and stronger MedSurg growth. SYK’s gross margin was weaker than we had expected though it was able to offset this with SG&A leverage. SYK is now excluding amortization from its adjusted EPS. While we now have estimates both including and excluding amortization in our model, we have (reluctantly) changed our … Continue reading Stryker Posts Solid Results as Recon Market Strengthens